ADDICTION BIOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to advancing the understanding of addiction science. With an impressive impact factor and recognized as a Q1 journal in Medicine, Pharmacology, and Psychiatry and Mental Health, ADDICTION BIOLOGY occupies a crucial position in the scientific discourse surrounding the biological and neurochemical underpinnings of addictive behaviors. Since its inception in 1996, the journal has been at the forefront of research, fostering interdisciplinary collaborations and promoting innovative studies that explore the complexities of addiction. Researchers and professionals benefit from the journal's commitment to high-quality manuscripts, offering essential insights into prevention, treatment, and rehabilitation strategies for substance use disorders. Although it does not offer open access, ADDICTION BIOLOGY remains accessible through various academic libraries, ensuring that groundbreaking studies reach a global audience. This journal is indispensable for anyone seeking to deepen their knowledge in the rapidly evolving field of addiction research.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Behavioral Neuroscience, published by the American Psychological Association, is a leading academic journal in the field of behavioral neuroscience, which focuses on the biological underpinnings of behavior across various contexts. Established in 1983, this journal has been a vital resource for researchers and professionals seeking to understand the intersection between neural processes and behavioral patterns. With an impressive impact factor that positions it in the Q2 category of Behavioral Neuroscience for 2023, it ranks 58th out of 88 journals in its field, showcasing its significance as a contributor to scientific literature. The journal fosters the dissemination of high-quality research and innovative theories that address critical questions in neuroscience, providing a platform for interdisciplinary collaboration. While it does not offer open access, the extensive distribution through academic libraries ensures wide availability for students, practitioners, and researchers alike. By continuing to publish cutting-edge articles through 2024 and beyond, Behavioral Neuroscience remains essential for those looking to stay at the forefront of advancements in understanding the biological mechanisms of behavior.

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

Brain Imaging and Behavior is a premier journal published by SPRINGER, dedicated to advancing the understanding of the relationship between brain function and behavior through innovative imaging techniques. Since its inception in 2007, the journal has provided a crucial platform for researchers and professionals in fields such as Behavioral Neuroscience, Cognitive Neuroscience, and Psychiatry and Mental Health. With an impressive ranking within the Q1 category in Radiology, Nuclear Medicine and Imaging and maintaining strong Q2 status in several other categories, the journal is positioned as a leading resource for groundbreaking research. The journal aims to disseminate high-quality studies that explore neurobiological underpinnings of behavior, utilizing cutting-edge imaging technologies. Although it is not an open-access journal, the visibility and impact of published works in Brain Imaging and Behavior continue to influence the scientific community significantly, underscoring the critical intersection between imaging science and neuroscience.

EUROPEAN PSYCHIATRY, published by Cambridge University Press, stands at the forefront of advancements in the field of psychiatry and mental health, serving as a vital resource for researchers, professionals, and students alike. With an impressive Q1 ranking in Psychiatry and Mental Health and an impact factor that underscores its significance, this journal fosters innovative studies and discussions that shape contemporary understanding of mental health issues. Offering Open Access since 2020, it ensures that high-quality research is readily available to a global audience, bridging gaps in knowledge dissemination. The journal, which has been publishing since 1991, encompasses a broad range of topics relevant to mental health, emphasizing evidence-based practices and interdisciplinary approaches to treatment and care. With its ongoing commitment to excellence, EUROPEAN PSYCHIATRY continues to be an indispensable platform for advancing the science of mental health.

BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

Biological Psychiatry is a premier journal dedicated to advancing the understanding of the biological underpinnings of psychiatric disorders. Published by Elsevier Science Inc, this esteemed journal is recognized globally for its rigorous peer-reviewed research and contributes significantly to the field of biological psychiatry. With an impressive impact factor that places it in Q1 of its category and ranks 3rd out of 51 in Neuroscience Biological Psychiatry, it reflects the journal's strength in disseminating high-quality findings that push the boundaries of knowledge. Since its inception in 1969, the journal has undergone continuous evolution, aiming to integrate biological and clinical perspectives to optimize the understanding of mental health conditions. Although it does not offer open access, Biological Psychiatry serves as a critical resource for researchers, practitioners, and students, offering insights that influence both theoretical frameworks and practical applications in the realm of psychiatric science.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.